- Home
- SPT vs PRME Comparison
SPT vs PRME Comparison
Compare SPT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPT
- PRME
- Stock Information
- Founded
- SPT 2010
- PRME 2019
- Country
- SPT United States
- PRME United States
- Employees
- SPT 1322
- PRME N/A
- Industry
- SPT Computer Software: Prepackaged Software
- PRME Medicinal Chemicals and Botanical Products
- Sector
- SPT Technology
- PRME Health Care
- Exchange
- SPT Nasdaq
- PRME Nasdaq
- Market Cap
- SPT 687.5M
- PRME 693.5M
- IPO Year
- SPT 2019
- PRME 2022
- Fundamental
- Price
- SPT $11.06
- PRME $5.77
- Analyst Decision
- SPT Buy
- PRME Buy
- Analyst Count
- SPT 10
- PRME 6
- Target Price
- SPT $27.70
- PRME $8.88
- AVG Volume (30 Days)
- SPT 1.4M
- PRME 4.1M
- Earning Date
- SPT 11-05-2025
- PRME 11-11-2025
- Dividend Yield
- SPT N/A
- PRME N/A
- EPS Growth
- SPT N/A
- PRME N/A
- EPS
- SPT N/A
- PRME N/A
- Revenue
- SPT $430,795,000.00
- PRME $4,961,000.00
- Revenue This Year
- SPT $13.14
- PRME $179.58
- Revenue Next Year
- SPT $11.88
- PRME N/A
- P/E Ratio
- SPT N/A
- PRME N/A
- Revenue Growth
- SPT 14.79
- PRME 739.42
- 52 Week Low
- SPT $11.51
- PRME $1.11
- 52 Week High
- SPT $36.30
- PRME $6.94
- Technical
- Relative Strength Index (RSI)
- SPT 22.11
- PRME 56.37
- Support Level
- SPT $12.27
- PRME $5.66
- Resistance Level
- SPT $11.88
- PRME $6.85
- Average True Range (ATR)
- SPT 0.53
- PRME 0.58
- MACD
- SPT -0.12
- PRME -0.00
- Stochastic Oscillator
- SPT 1.50
- PRME 41.37
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.